Neuroprotective Effects of Phenolic Compounds in Neurodegenerative Disorders
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The hallmarks of neurodegenerative diseases include mitochondrial dysfunction, which leads to oxidative stress, inflammatory processes, and apoptosis, all of which contribute to the cytotoxicity and degeneration of cells. The three main neurodegenerative illnesses are Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease (HD). Thus far, scientists have identified various naturally occurring secondary metabolites that may have therapeutic applications for neurodegenerative diseases. More specifically, owing to their numerous biological functions and potential therapeutic benefits for human health, phenolic metabolites have gained increasing popularity recently. Naturally, polyphenol components play a crucial role in neurological protection and may mitigate the damaging effects of inflammatory processes, oxidative stress, and apoptosis by modulating various cellular activities. The present state of research on phenolic compounds, including flavonoids, coumarins, phenolic acids, and stilbenes, and their neuroprotective and positive health benefits, as determined by in vitro studies, is the main topic of this chapter. Furthermore, an outline of the therapeutic impacts of natural polyphenolics and plausible action pathways in managing neurodegenerative diseases was presented.
Fields of Study & Subjects
Medicinal Plants and Neuroprotection
Phytochemicals and Antioxidant Activities
Neuroprotection in Cerebral Ischemia
Publication details
- Journal / source
- CRC Press eBooks
- Pages
- 136–149
- Publication date
- 1 April 2026
- Language
- EN
- Document type
- Book chapter